Skip to main content
. Author manuscript; available in PMC: 2024 Aug 6.
Published in final edited form as: Cancer Epidemiol Biomarkers Prev. 2024 Feb 6;33(2):215–223. doi: 10.1158/1055-9965.EPI-23-0507

Figure 1.

Figure 1.

Study cohort assembly flowchart.

The entire analytical sample of 56,980 patients was used to calculate prevalence and assess predictors of unsatisfactory FIT. Of these, 3,790 patients had at least 15-month follow-up after the unsatisfactory FIT and were used to determine prevalence of subsequent test after the unsatisfactory FIT.